BB Biotech

BB Biotech stands as a prominent force in investment management, offering unparalleled access to fast-growing biotech companies since 1993. With over 30 years of experience, BB Biotech has established itself as one of the world's largest investors in the biotechnology sector.

BB Biotech focuses its investments on listed companies that are at the forefront of developing and commercializing innovative drugs. These novel therapeutics not only promise to advance healthcare but also offer significant value to the healthcare system. BB Biotech is committed to supporting companies that are making a tangible difference in the lives of patients worldwide.

The shares of BB Biotech are publicly traded on the SIX Swiss Exchange, the Frankfurt Stock Exchange, and the Stock Exchange in Milan, reflecting its strong market presence and investor confidence. BB Biotech's primary address is Schwertstrasse 6, Schaffhausen, 8200, CH. We invite the manager of BB Biotech to create a customized and exclusive company showcase and product listing on our platform to further amplify its reach and impact.